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Abstract
Background—The mainstay of treatment in adenoid cystic carcinoma (ACC) of the head and 
neck is surgical resection with negative margins. The purpose of this study was to define the 
margin status that associates with survival outcomes of ACC of the head and neck.
Methods—We conducted univariate and multivariate analyses of international data.
Results—Data of 507 patients with ACC of the head and neck were analyzed; negative margins 
defined as ≥5 mm were detected in 253 patients (50%). On multivariate analysis, the hazard ratios 
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(HRs) of positive margin status were 2.68 (95% confidence interval [CI], 1.2–6.2; p = .04) and 
2.63 (95% CI, 1.1–6.3; p = .03) for overall survival (OS) and disease-specific survival (DSS), 
respectively. Close margins had no significant impact on outcome, with HRs of 1.1 (95% CI, 0.4–
3.0; p = .12) and 1.07 (95% CI, 0.3–3.4; p = .23) for OS and DSS, respectively, relative with 
negative margins.
Conclusion—In head and neck ACC, positive margins are associated with the worst outcome. 
Negative or close margins are associated with improved outcome, regardless of the distance from 
the tumor.
Keywords
adenoid cystic carcinoma; survival; margins; paranasal sinuses; oral cavity; salivary gland; head 
and neck cancer
INTRODUCTION
Adenoid cystic carcinoma (ACC) accounts for 3% to 5% of all head and neck malignancies. 
ACC is characterized by an intermediate growth rate, local invasiveness, low probability of 
lymphatic spread, and frequent lung metastases.1,2
Surgery is the primary treatment for ACC of the head and neck.3,4 In the skull base, ACC is 
typically diagnosed late, and the proximity to vital structures (eg, dura, brain, orbit, and 
central nerves) makes adequate oncologic resection more complex.5,6 In head and neck 
squamous cell carcinoma (HNSCC), margins that are <5 mm have been associated with 
worse outcome.7,8 Similarly, positive surgical margin status in ACC is considered a poor 
prognostic factor.9,10 Nevertheless, the impact of close margins, defined as a tumor-free 
margins of <5 mm, in ACC of the head and neck is unclear.3,11,12 Most reports on head and 
neck ACC are based on small single institute cohorts, and tumors from different anatomic 
locations are grouped together, as are tumors subjected to different treatment regimens; 
information on predictors of outcomes in this specific population is sparse.3,13
In the present international multicenter study, our purpose was to characterize the impact of 
close margins in ACC of the head and neck.
PATIENTS AND METHODS
Patients
Our study cohort comprised all patients (n = 507) who were treated for ACC between 1985 
and 2014 in 9 cancer centers worldwide, for whom data and archival slides for examination 
were available.2 The study was approved by the local institutional review board committees 
of the participating centers. The age of the patients ranged from 16 to 91 years (median, 57 
years). Their median follow-up was 73 months (range, 12–306 months). All patients 
underwent primary surgery, with or without adjuvant radiotherapy or chemoradiation. A 
standardized neck dissection involving levels I, I to III, or I to IV/V was performed in 265 
patients (52%), as described by the American Head and Neck Society.14 The type of neck 
dissection was preoperatively specified in all patients.
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Histopathological analysis
Specimen dissections, as well as tissue sampling of the primary tumor, were carried out 
according to current guidelines for the histopathological assessment of head and neck 
cancer.15 If any of the resection margins was involved by ACC, the case was classified as a 
positive margin, if the resection margins were not involved, yet <5 mm from the tumor, the 
case was classified as a close margin. The cases were examined for the presence or absence 
of perineural invasion, which was defined as the presence of viable tumor cells in the 
perineural space. The pathologic staging was classified according to the American Joint 
Committee on Cancer Staging Manual, seventh edition.16
Statistical analysis
Five-year overall survival (OS) and disease-specific survival (DSS) rates were calculated 
using the Kaplan–Meier method, and the differences in survival rates were assessed by the 
log-rank test.17 OS was measured from the date of diagnosis to the date of death or last 
follow-up. DSS was calculated from the date of diagnosis to the date of death as a result of 
ACC or censored at the date of last follow-up. The variables that had prognostic potential, as 
indicated by univariate analyses, were subjected to multivariate analyses with the Cox 
proportional hazards regression model.18 All analyses were performed on JMP software 
(SAS Institute, Cary, NC) and confirmed by an independent statistician on the IBM SPSS 
Statistics package (IBM, Armonk, NY). All p values were 2-sided, and a value of < .05 
indicated statistical significance. Variables used to stratify survival included age, sex, T 
classification, N classification, M classification, margin status, perineural invasion, 
lymphovascular invasion, treatment group (ie, surgery alone vs surgery and radiation vs 
surgery and chemoradiation), and tumor grade (solid, tubular, and cribriform). Cases with 
involvement of ACC outside of the oral cavity, paranasal sinuses, skull base, or major 
salivary glands were excluded from the analysis because of a low number of cases (n = 7).
RESULTS
Data of 507 patients with ACC of the head and neck were analyzed; 154 patients (30%) had 
ACC of a major salivary gland, 242 patients (48%) had ACC of the oral cavity, and 111 
patients (22%) had ACC of the paranasal sinuses. Table 1 presents the clinicopathological 
variables of the patients. Negative margins were detected in 38% of patients with advanced 
local disease (T3 to T4 classification) and in 59% of patients with early disease (p < .0001). 
Adjuvant treatment was administered in 57% of the patients with negative margins, 
compared to 68% and 78% of those with close and positive margins, respectively. Negative 
margins were achieved in 57% of the patients with oral cavity ACC compared to 49% and 
35% of those with major salivary glands and paranasal sinus ACC, respectively (p = .001). 
Neck dissection was performed on 265 patients (52%); of them, 74 patients (38%) had nodal 
metastases. Rates of nodal metastasis were 17%, 14%, and 14% for patients with positive, 
close, and negative margin status, respectively (p = .6).
The 5-year and 10-year postoperative OS rates for patients with ACC of the head and neck 
were 74% and 55%, respectively; the respective DSS rates were 78% and 60%. As shown in 
Figure 1, the 5-year OS rates for positive, close, and negative margins were 63%, 71%, and 
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79%, respectively (p < .001); the respective 5-year DSS rates were 69%, 75%, and 83% (p 
= .003). Disease-free survival rates were 86%, 74%, and 69% for negative, close, and 
positive margins, respectively (p = .01). We found significantly higher rates of local 
recurrence (p = .01) and distant metastases (p = .009), but not for regional recurrence-free 
survival (p = .08; Figure 2).
Next, we assessed the survival outcomes for each subsite according to margin status. For 
oral cavity ACC, the 5-year OS rate was 83%, 74%, and 73% for patients with negative, 
close, and positive surgical margins, respectively (p = .012); the respective 5-year DSS rates 
were 86%, 80%, and 75% (p = .043). For patients with major salivary gland ACC, the 5-year 
OS rate did not differ significantly by margin status (74%, 70%, and 67%, respectively; p = .
57) and DSS (80%, 77%, and 75%, respectively; p = .65). For patients with ACC of the 
paranasal sinuses and skull base, the respective 5-year OS rates were 74%, 72%, and 41% (p 
= .009); and the respective 5-year DSS rates were 77%, 75%, and 40% (p = .003).
Factors that were associated with outcome on univariate analysis were: margin status, pT 
classification, overall TNM classification, tumor site, intraneural invasion, and bone invasion 
(Table 2). These factors were then evaluated in a multivariate model (Table 3). Hazard ratios 
(HRs) for positive margin status were 2.68 (95% confidence interval [CI], 1.2–6.2; p = .04) 
and 2.63 (95% CI, 1.1–6.3; p = .03) for OS and DSS, respectively. Compared with negative 
margins, close margins had similar impact on survival, with HRs of 1.1 (95% CI, 0.4–3.0; p 
= .12) and 1.07 (95% CI, 0.3–3.4; p = .23) for OS and DSS, respectively. Other variables 
that showed independent impact on outcome were: T classification, overall TNM 
classification, and intraneural invasion of the tumor.
DISCUSSION
Local recurrence and survival in head and neck malignant neoplasms are significantly 
associated with the involvement of margins.19–21 Sound oncologic surgery requires an 
adequate margin of normal tissue around the tumor. For HNSCC, the American Joint 
Committee on Cancer and the Union for International Cancer Control guidelines have 
focused on involved margins, whereas the National Comprehensive Cancer Network and the 
American Society of Clinical Oncology guidelines define close margins as <5 mm, without 
any distinction for anatomic subsite.22–25 However, there is currently no published data that 
defines the required width of this margin for ACC. Available literature does not refer to the 
prognostic value of margin status and its potential contribution to decision-making. 
Furthermore, assessment of the specific prognostic value of close margins is especially 
lacking, and some authors consider positive and close margins jointly in follow-up 
assessment.26–28 Conversely, some studies of head and neck malignancies, particularly those 
involving paranasal sinuses, have grouped together outcomes according to margin status for 
different histologies (including ACC).19 This is despite the knowledge that histological 
varieties differ regarding pattern of invasion, spread, and risk of recurrence.
The best results for treatment of salivary gland tumors are achieved by complete tumor 
resection.3,7,29 Complete surgical resection, which is largely dependent on tumor size, site, 
and surgeon, is the single most important prognostic factor for patients with these tumors.
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21,29
 Unlike HNSCC, for ACC, there is lack of standardization of margins status and no 
range of distance is currently considered for the definition of “close” in published studies.
3,29,30
 Hence, even the definition used by various authors for positive margin status is 
obscure and may affect survival, despite the application of the same type of surgery. Efforts 
to identify reliable prognostic factors in ACC have dominated the literature for the last 
decade.2,3,30–32 Consensus has not been reached regarding the key prognostic factors. 
Margins status was found significant for survival by some,3 whereas others did not find 
positive margins to significantly influence survival.31 In the current analysis, close margin 
status of <5 mm was analyzed as a separate risk group. Our data suggest that although 
positive margins in ACC are independently associated with worse outcome, patients with 
close margin status have similar OS and DSS as those with negative margins.
The ability to achieve wide free margins accounts for a variety of parameters, including 
tumor site, T classification, pattern of invasion, and prior treatment. In many cases, surgery 
is limited by proximity to vital structures. Patients with ACC arising from sites in proximity 
to the skull base (nasopharynx, nasal cavity, and paranasal sinuses) have been shown to have 
a significantly increased risk of local recurrence.3 This is related to the difficulty of securing 
clear resection margins because of dense involvement of the skull base, dura, cranial nerves, 
or carotid artery, restricting the limits of resection. Achieving safe oncologic resection in 
these cases might entail significant morbidity for the patient, such as cranial nerve palsy or 
cerebrospinal fluid rhinorrhea.
Our subsite analysis showed similar outcomes for negative and close margin status for 
patients with ACC of the paranasal sinuses; whereas for patients with oral cavity ACC, close 
margin status represented a separate risk group with worse outcome than negative margins, 
although the difference did not reach statistical significance. In such an instance, a surgeon 
should balance between the advantage of achieving margins wider than 5 mm and potential 
resultant morbidity.
Achieving negative margins in ACC is also challenging because of its propensity for local 
invasion and neural invasion in particular.32 In many cases, the presence of perineural 
invasion in specimens with “negative” margins is considered an independent factor that 
would have benefited from the addition of radiotherapy.3,24 Perineural invasion is likely 
associated with clinical parameters, such as tumor cells at the surgical margin, major 
salivary gland tumors, and advanced stage.33 We previously showed that intraneural invasion 
and not perineural invasion is associated with poor outcome.32
The routine use of radiotherapy in ACC is not clearly defined because of lack of level-1 
evidence. Physicians frequently advocate adjuvant radiotherapy for patients with locally 
advanced tumors, or for those with histologically positive or close margins.24 In HNSCC, 
adjuvant treatment in the form of chemoradiation is recommended for close or positive 
margins.34,35 As current recommendations do not directly address close margin status for 
ACC, treatment decisions are frequently based on recommendations for HNSCC. Although 
the role of chemoradiation in ACC is not clear, this treatment carries significant morbidity 
and its use in a relatively radioresistant tumor, such as ACC, is controversial. Our data 
revealed that positive margin status harbors worse survival outcome on multivariate analysis; 
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however, close margin status did not affect outcomes significantly. Further study is needed to 
assess the utility of radiotherapy in patients with ACC in general, and in those with different 
margin status, specifically.
Our study had several limitations. First, possible inconsistencies in the surgical technique, 
adjuvant treatment, and processing of the pathological specimens may introduce errors. This 
prospective analysis of margins by each institutional head and neck pathologist did not 
enable analysis of the concordance rate for margin status between pathologists. Second, 
data, such as the occurrence of ACC among other cancer types, in each institute are lacking. 
The strength of this study stems from the use of individual data from 9 comprehensive 
cancer centers worldwide, which should increase the robustness and generalizability of the 
findings.
In conclusion, our study demonstrated that in head and neck ACC, positive margins are 
associated with the worst outcome, whereas negative and close margins are associated with 
improved outcome, regardless of the distance from the tumor. The presence of close margin 
status resulted in similar outcome as negative margins for ACC of all sites examined except 
the oral cavity. Negative margins should be achieved whenever possible in this disease. 
However, when wide resection requires removing a vital structure, achievement of close 
margins offers lesser morbidity without jeopardizing outcome.
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FIGURE 1. 
(A) Overall survival and (B) disease-specific survival rates for patients with adenoid cystic 
carcinoma of the head and neck (N = 507) with positive (green), close (red), and negative 
(blue) margin status, calculated by the Kaplan–Meier method. [Color figure can be viewed at 
wileyonlinelibrary.com]
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FIGURE 2. 
(A) Disease-free survival, (B) local recurrence–free survival, (C) regional recurrence–free 
survival, and (D) distant metastasis–free survival rates for patients with adenoid cystic 
carcinoma of the head and neck (N = 507) with positive (green), close (red), and negative 
(blue) margin status, calculated by the Kaplan–Meier method. [Color figure can be viewed at 
wileyonlinelibrary.com]
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TABLE 1
Patient demographic and clinical characteristics.
Variables
No. of patients (%)
N = 507 100%
Age, y, mean ± SD 56 ± 15
Sex
 Male 218 (43)
 Female 289 (57)
T classification
 1 125 (25)
 2 159 (31)
 3   75 (14)
 4 149 (30)
N classification
 N0 428 (82)
 N1 42 (8)
 N2 31 (7)
 N3     1 (<1)
M classification
 0 478 (95)
 1 24 (5)
Site
 Oral cavity 154 (30)
 Paranasal sinuses 242 (48)
 Major salivary glands 111 (22)
Margin status
 Positive 162 (32)
 Close, <5 mm   92 (18)
 Negative 253 (50)
Perineural invasion
 Present 237 (47)
 Absent 270 (53)
Lymphovascular invasion
 Present 35 (7)
 Absent 134 (26)
Bone invasion
 Present 187 (37)
 Absent 318 (63)
Treatment modality
 Surgery 175 (35)
 Surgery and RT 239 (47)
 Surgery and CRT   81 (16)
 Surgery and chemotherapy 12 (2)
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Variables
No. of patients (%)
N = 507 100%
Neck management
 Neck dissection 265 (52)
 No neck dissection 242 (48)
Follow-up
 Months 73 ± 29
Abbreviations: RT, radiotherapy; CRT, chemoradiotherapy.
Head Neck. Author manuscript; available in PMC 2018 May 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Amit et al. Page 13
TABLE 2
Univariate analysis of prognostic factors.
Variables
OS DSS
p value 5-y survival, % p value 5-y survival, %
Sex
 Male .9 74 .7 76
 Female 77 79
Age, y <.001 2/per y .001 1.9/per y
T classification
 T1 .03 86 .02 89
 T2 77 82
 T3 67 73
 T4 65 68
N classification
 N0 .1 78 .2 81
 N1 57 69
 N2 46 53
M classification
 M0 .7 74 .5 78
 M1 55 61
Overall TNM classification
 I .006 96 .01 97
 II 82 85
 III 59 61
 IV 58 61
Site
 Oral cavity .03 71 .02 76
 Paranasal sinuses 69 72
 Major salivary glands 78 83
Margins
 Negative <.001 83 .003 86
 Close, <5 mm 74 80
 Positive 73 75
Intraneural invasion
 No .006 78 .003 80
 Yes 54 .003 55
Lymphovascular invasion
 No .1 66 .3 67
 Yes 47 52
Bone invasion
 No .03 78 .04 81
 Yes 69 69
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Variables
OS DSS
p value 5-y survival, % p value 5-y survival, %
Treatment
 Surgery .4 77 .4 79
 Surgery and RT 75 78
 Surgery and CRT 64 67
 Surgery and chemotherapy 68 68
Neck management
 Neck dissection .02 69 .1 74
 No neck dissection 80 83
Differentiation
 Tubular .6 82 .8 85
 Cribriform 79 80
 Solid 74 79
Abbreviations: OS, overall survival; DSS, disease-specific survival; RT, radiotherapy; CRT, chemoradiotherapy.
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